SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049938
Filing Date
2024-04-29
Accepted
2024-04-29 16:30:15
Documents
4
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A snse-proxy-2024_non-xbrl.htm DEF 14A 836442
2 GRAPHIC img184115460_0.jpg GRAPHIC 33415
3 GRAPHIC img184115460_1.jpg GRAPHIC 1401331
4 GRAPHIC img184115460_2.jpg GRAPHIC 225239
  Complete submission text file 0000950170-24-049938.txt   3121846
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39980 | Film No.: 24891431
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)